The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation
Journal: Health Technology Assessment
•
• NIHR Journals Library
• ISSN:
1366-5278
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
A Takeda, J Jones, E Loveman, et al. (2007). "The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation". Health Technology Assessment. https://doi.org/10.3310/hta11190